Endobronquial ultrasound transbronchial needle aspiration (EBUS-TBNA) performance for the determination of Programmed Death Ligand-1 (PDL-1) expression in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Zuil Moreno, M. [1 ,2 ]
Polanco, D. [1 ,2 ]
Gracia-Lavedan, E. [2 ,3 ]
Pinilla, L. [2 ,3 ]
Gatius, S. [4 ]
Barbe, F. [1 ,2 ,3 ]
机构：
[1] Hosp Arnau Vilanova, Resp Dept, Lleida, Spain
[2] Translat Res Resp Med Grp TRRM, Lleida, Spain
[3] CIBERES, Madrid, Spain
[4] Hosp Univ Arnau de Vilanova & Santa Maria, Pathol Dept, Lleida, Spain
来源：
EUROPEAN RESPIRATORY JOURNAL | 2022年 / 60卷
关键词：
D O I：
10.1183/13993003.congress-2022.2420
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2420
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Correlation of Programmed Cell Death Ligand-1 Messenger RNA and Protein Expression in Non-Small Cell Lung Cancer
    Kwon, H. J.
    Kim, H.
    Park, S. Y.
    Park, E.
    Chung, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2243 - S2244
  • [32] Endobronchial ultrasound (EBUS) with tranbronchial needle aspiration (TBNA) versus mediastinoscopy for mediastinal staging in non-small cell lung cancer (NSCLC) thoracic cancer
    Nasir, Basil
    Cerfolio, Robert J.
    Bryant, Ayesha S.
    THORACIC CANCER, 2012, 3 (02) : 131 - 138
  • [33] Harmonization of programmed cell death ligand-1 diagnostic assays in non-small cell lung cancer
    Popple, Amy
    Illidge, Timothy M.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S553 - S556
  • [34] Programmed Death Ligand-1 (PD-L1) Expression in Patients with Non-Small Cell Lung Cancer (NSCLC) with Unusual Metastasis: A Case Series
    Tsugitomi, R.
    Nishimura, N.
    Imai, R.
    Okafuji, K.
    Kitamura, A.
    Tomishima, Y.
    Jinta, T.
    Suzuki, K.
    Tamura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [35] Programmed Death Ligand-1 Expression in Non-Small Cell Lung Cancer in Mexican Population and Correlation with Clinicopathologic Features
    Bornstein, L.
    Macedo-Perez, O.
    Lyra Gonzalez, I.
    Bautista-Wong, C.
    Cienfuegos-Meza, J.
    Campos-Peralta, K.
    Jimenez-Fuentes, E.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S504 - S505
  • [36] Assessment of programmed cell death ligand-1 expression with multiple immunohistochemistry antibody clones in non-small cell lung cancer
    Pang, Chen
    Yin, Limei
    Zhou, Xiaojuan
    Lei, Chuanfen
    Tong, Ruizhan
    Huang, Meijuan
    Gong, Youling
    Ding, Zhenyu
    Xue, Jianxin
    Zhu, Jiang
    Wang, Yongsheng
    Ren, Li
    Zhou, Lin
    Wang, Jin
    Peng, Feng
    Zhou, Qiao
    Lu, You
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 816 - 824
  • [37] Programmed Cell Death Ligand 1 Expression in Resected Non-Small Cell Lung Cancer
    Yu, Hui
    Brustugun, Odd Terje
    Ekman, Simon
    Botling, Johan
    La Fleur, Linnea
    Micke, Patrick
    Solberg, Steinar
    Berglund, Anders
    Rivard, Christopher
    Hirsch, Fred R.
    CLINICAL LUNG CANCER, 2021, 22 (04) : E555 - E562
  • [38] Programmed death ligand 1 expression in EBUS aspirates of non-small cell lung cancer: Is interpretation affected by type of fixation?
    Gosney, John R.
    Haragan, Alexander
    Chadwick, Claire
    Giles, Tom E.
    Grundy, Seamus
    Tippett, Victoria
    Gumparthy, Krishna P.
    Wight, Andrew
    Tan, Hock G.
    CANCER CYTOPATHOLOGY, 2020, 128 (02) : 100 - 106
  • [39] The advantages of endobronchial ultrasound guided needle aspiration (EBUS/EUS-TBNA) in staging of non-small cell lung cancer
    Becker, Heinrich D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S182 - S182
  • [40] Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
    Tan, Shera
    Sharma, Kiran
    Tham, Kah Yee
    Ang, Shin Yuh
    Van Hai Nguyen
    Lapperre, Therese Sophie
    Loo, Chian Min
    Koh, Mariko Siyue
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
12345